磨牙远移的高效矫治方案及临床验证

注册号:

Registration number:

ChiCTR2100041779 

最近更新日期:

Date of Last Refreshed on:

2021-03-22 13:32:36 

注册时间:

Date of Registration:

2021-01-05 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

磨牙远移的高效矫治方案及临床验证

Public title:

The effective treatment plan and clinical verification of molars distalization

注册题目简写:

English Acronym:

研究课题的正式科学名称:

磨牙远移的高效矫治方案及临床验证

Scientific title:

The effective treatment plan and clinical verification of molars distalization

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

姜若萍 

研究负责人:

姜若萍 

Applicant:

Ruoping Jiang 

Study leader:

Ruoping Jiang 

申请注册联系人电话:

Applicant telephone:

+86 10-82195729

研究负责人电话:

Study leader's
telephone:

+86 10-82195729

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

jiangruoping@126.com

研究负责人电子邮件:

Study leader's E-mail:

jiangruoping@126.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

北京市海淀区中关村南大街22号

研究负责人通讯地址:

北京市海淀区中关村南大街22号

Applicant address:

22 Zhongguancun South Avenue, Haidian District, Beijing, China

Study leader's address:

22 Zhongguancun South Avenue, Haidian District, Beijing, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

北京大学口腔医院

Applicant's institution:

Peking University Hospital of Stomatology

研究负责人所在单位:

北京大学口腔医院

Affiliation of the Leader:

Peking University Hospital of Stomatology

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

PKUSSIRB-202059157

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

北京大学口腔医院生物医学伦理委员会

Name of the ethic committee:

Peking University Hospital of Stomatology Biomedical Ethics Committee

伦理委员会批准日期:

Date of approved by ethic committee:

2020-11-30 00:00:00

伦理委员会联系人:

贾效伟

Contact Name of the ethic committee:

Xiaowei Jia

伦理委员会联系地址:

北京市海淀区中关村南大街22号

Contact Address of the ethic committee:

22 Zhongguancun South Avenue, Haidian District, Beijing, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

北京大学口腔医院

Primary sponsor:

Peking University Hospital of Stomatology

研究实施负责(组长)单位地址:

北京市海淀区中关村南大街22号

Primary sponsor's address:

22 Zhongguancun South Avenue, Haidian District, Beijing, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

北京

市(区县):

Country:

China

Province:

Beijing

City:

单位(医院):

北京大学口腔医院

具体地址:

海淀区中关村南大街22号

Institution
hospital:

Peking University Hospital of Stomatology

Address:

22 Zhongguancun South Avenue, Haidian District

经费或物资来源:

自筹经费

Source(s) of funding:

Self-organized

研究疾病:

口腔错颌畸形  

Target disease:

Malocclusion

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

本研究将建立全牙列的高精度可视化模型,从而获取牙周膜面积在各牙位的分布的全面数据,比较隐形矫治传统磨牙分步远移方案与经过个性化牙齿三维模型在MasterForce力学测试平台模拟测试后设计的远移方案的差异,并据此探索符合生物力学的磨牙远移高效矫治方案。  

Objectives of Study:

In this research we will build full denture visual model which has high precision, so as to obtain a comprehensive data of periodontal membrane area in various tooth.Then we will compare the traditional molar step moving scheme with personalized molar distalization plan which patient's 3D teeth model tested in MasterForce mechanics simulation test. Finally, according to the differences between the two plans we can explore the effective orthodontic protocol that meets the biomechanics of molar distalization.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

1.颌面部存在严重骨性不对称畸形、开合畸形或偏合畸形;
2.颌面部外伤、手术、正畸史;
3.颌面部软组织发育缺陷或软组织不对称超过5mm;
4.接受正畸正颌联合治疗;
5.存在除第三磨牙外的牙齿缺失;
6.牙列存在重度拥挤需进行拔牙正畸矫治;
7.中-重度牙周炎;
8.面颌骨有实质性病变;
9.颞下颌关节紊乱病并有明显的临床症状;
10.治疗前及治疗期间体质BMI指数超出范围要求;
11.实验前及研究过程中接受面部整形相关治疗;
12.受试者因其他个人原因需退出本研究。

Exclusion criteria:

1.Severe bone asymmetry malformation, opening and closing malformation or deviated malformation exist in maxillofacial region;
2.Maxillofacial trauma, surgery, orthodontic history;
3.Maxillofacial soft tissue defect or soft tissue asymmetry more than 5mm;
4.Received orthodontic and orthognathic combined treatment;
5.Absence of teeth other than the third molars;
6.Tooth extraction orthodontic treatment was needed for severe dentition congestion;
7.Moderate to severe periodontitis;
8.The facial jaw has substantial lesion;
9.Temporomandibular joint disorder with obvious clinical symptoms;
10.BMI exceeds the range requirements before and during treatment;
11.Facial plastic surgery was performed before and during the study;
12.Subjects need to withdraw from the study for other personal reasons.

研究实施时间:

Study execute time:

From 2021-01-01 00:00:00 To 2023-12-30 00:00:00  

征募观察对象时间:

Recruiting time:

From 2021-01-01 00:00:00 To 2021-12-30 00:00:00

干预措施:

Interventions:

组别:

A

样本量:

15

Group:

A

Sample size:

干预措施:

传统磨牙分步移动矫治

干预措施代码:

Intervention:

Traditional molar step moving treatment

Intervention code:

组别:

B

样本量:

15

Group:

B

Sample size:

干预措施:

个性化磨牙远移矫治

干预措施代码:

Intervention:

Personalized molar distalization treatment

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

北京 

市(区县):

 

Country:

China

Province:

Beijing

City:

单位(医院):

北京大学口腔医院 

单位级别:

三级甲等 

Institution
hospital:

Peking University Hospital of Stomatology

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

牙列模型标志点

指标类型:

主要指标

Outcome:

Dental model landmarks

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

面部硬组织标志点

指标类型:

主要指标

Outcome:

Facial hard tissue landmarks

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

面部软组织标志点

指标类型:

主要指标

Outcome:

Facial soft tissue landmarks

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 12 years
最大 Max age 40 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

最小化随机分组

Randomization Procedure (please state who generates the random number sequence and by what method):

Minimized random grouping

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

未说明

Blinding:

Not stated

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

ResMan 临床试验公共管理平台, http://www.medresman.org.cn

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

ResMan, http://www.medresman.org.cn.

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

利用计算机测量相关项目,并将结果手工录入EXCEL表格中,由研究者将数据保存在实验室计算机中,并定期进行备份。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

EXCEL,stored in the computers of laboratory.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2021-01-05 15:23:01